Cargando…

Are anthropometric data a tool for determining the severity of OHSS? Yes, it could be!

BACKGROUND: All management guidelines of ovarian hyperstimulation syndrome (OHSS) recommend daily monitoring of women's body weight, waist circumference and note that as indicators increase, the severity OHSS also increases. However, the dynamics of abdominal size and its relationship with mark...

Descripción completa

Detalles Bibliográficos
Autores principales:	Petrenko, Aleksei Petrovich, Castelo-Branco, Camil, Marshalov, Dimitry Vasilevich, Kuligin, Alexander Valerievich, Shifman, Efim Munevich, Nesnova, Elena Sergeevna, Olegovna, Batsunova Mariia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092801/ https://www.ncbi.nlm.nih.gov/pubmed/35538521 http://dx.doi.org/10.1186/s12905-022-01701-5

Ejemplares similares

OHSS Free Clinic
por: Devroey, P., et al.
Publicado: (2011)

New algorithm for OHSS prevention
por: Papanikolaou, Evangelos G, et al.
Publicado: (2011)

Current treatment options for postmenopausal vaginal atrophy
por: Naumova, Iuliia, et al.
Publicado: (2018)

Two Sisters with Kallmann Syndrome, Gonadal Dysgenesis, and Multiple Neuromuscular and Endocrine Disorders: Report of Two Cases with Description of an Unusual Association
por: Camacho, Marta, et al.
Publicado: (2022)

Ovarian hyperstimulation syndrome (OHSS) at a maternity hospital
por: Lappas, V, et al.
Publicado: (1999)

Early menopause: A hazard to a woman's health
por: Hernández-Angeles, Claudio, et al.
Publicado: (2016)

Are Pregnancy Rates Compromised Following Embryo Freezing to Prevent OHSS?
por: Fitzmaurice, Gerard J, et al.
Publicado: (2008)

Predictive factors for recovery time in patients suffering from severe OHSS
por: Nouri, Kazem, et al.
Publicado: (2014)

Revisiting ovarian hyper stimulation syndrome: Towards OHSS free clinic
por: Banker, Manish, et al.
Publicado: (2015)

Gonadotropin-releasing hormone agonist ovulation trigger—beyond OHSS prevention
por: Castillo, Juan Carlos, et al.
Publicado: (2020)

Letrozole and Ovarian Hyperstimulation Syndrome (OHSS): A Promising Prevention Strategy
por: Di Guardo, Federica, et al.
Publicado: (2023)

Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment
por: Fiedler, Klaus, et al.
Publicado: (2012)

Pregnancy outcome in severe OHSS patients following ascitic/plerural fluid drainage
por: Haas, Jigal, et al.
Publicado: (2014)

Outpatient Management of Severe Ovarian Hyperstimulation Syndrome (OHSS) with Placement of Pigtail Catheter
por: Abuzeid, M., et al.
Publicado: (2014)

Comparative analysis of abdominal fluid cytokine levels in ovarian hyperstimulation syndrome (OHSS)
por: Farkas, Balint, et al.
Publicado: (2020)

Biomarkers identification in follicular fluid of women with OHSS by using UPLC-MS method
por: Wu, Ze, et al.
Publicado: (2023)

Melatonin Ameliorates Ovarian Hyperstimulation Syndrome (OHSS) through SESN2 Regulated Antiapoptosis
por: Zheng, Min, et al.
Publicado: (2023)

Yes
por: Stanley, Arthur
Publicado: (1923)

Myo-inositol is a promising treatment for the prevention of ovarian hyperstimulation syndrome (OHSS): an animal study
por: Turan, Guluzar Arzu, et al.
Publicado: (2015)

Higher melatonin in the follicle fluid and MT2 expression in the granulosa cells contribute to the OHSS occurrence
por: Li, Yiran, et al.
Publicado: (2019)

Opinion: Yes
por: Vieira, Marcelo
Publicado: (2015)

Opinion: Yes
por: Althof, Stanley E.
Publicado: (2015)

Opinion: Yes
por: Cintra, Caio Cesar, et al.
Publicado: (2016)

Yes, It Does
por: Cummins, Nathan W.
Publicado: (2021)

Is the GnRH Antagonist Protocol Effective at Preventing OHSS for Potentially High Responders Undergoing IVF/ICSI?
por: Xing, Weijie, et al.
Publicado: (2015)

Erratum to: Myo-inositol is a promising treatment for the prevention of ovarian hyperstimulation syndrome (OHSS): an animal study
por: Turan, Guluzar Arzu, et al.
Publicado: (2016)

The effect of luteal phase gonadotropin-releasing hormone antagonist administration on IVF outcomes in women at risk of OHSS
por: Eftekhar, Maryam, et al.
Publicado: (2016)

The perspective of women with an increased risk of OHSS regarding the safety and burden of IVF: a discrete choice experiment
por: Braam, S C, et al.
Publicado: (2020)

An unusually prolonged course of late onset severe OHSS with successful outcome - a rare but avoidable complication
por: Malhotra, Neena, et al.
Publicado: (2022)

A Personalized Management Approach of OHSS: Development of a Multiphase Prediction Model and Smartphone-Based App
por: Cao, Mingzhu, et al.
Publicado: (2022)

Outpatient management of severe early OHSS by administration of GnRH antagonist in the luteal phase: an observational cohort study
por: Lainas, George T, et al.
Publicado: (2012)

Can steroidal ovarian suppression during the luteal phase after oocyte retrieval reduce the risk of severe OHSS?
por: Wang, Ya-Qin, et al.
Publicado: (2015)

Factors Associated with Ovarian Hyperstimulation Syndrome (OHSS) Severity in Women With Polycystic Ovary Syndrome Undergoing IVF/ICSI
por: Sun, Bo, et al.
Publicado: (2021)

Opisthorchiasis in infant remains from the medieval Zeleniy Yar burial ground of XII-XIII centuries AD
por: Slepchenko, Sergey Mikhailovich, et al.
Publicado: (2015)

Prophylactic Sclerotherapy: Yes or No!
por: Burroughs, A. K.
Publicado: (1996)

Yes, we did it!
por: CERN Bulletin
Publicado: (2010)

Yes, SiR
por: Fu, Xiang-Dong
Publicado: (2015)

Yes, research matters
por: Shinohara, Mari L.
Publicado: (2017)

Yes, it's caries again
por: Hancocks OBE, Stephen
Publicado: (2020)

Yes- mind the gap!
por: Hamsen, Uwe, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_o7vsupj6e3d5p3k3vsvgbodleg